SCHEMBL6533654

SCHEMBL6533654

CC1=C(C(=O)O)C(c2cccc([N+](=O)[O-])c2)NC(=O)N1CCCN(C)C(=O)COc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.55
ATM Q13315 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
HTT P42858 2/20 0.46
MAPT P10636 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CACNA1C Q13936 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PKM P14618 1/20 0.41
LMNA P02545 2/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6465916 0.86 ALDH1A1 (0.54) ALDH1A1ATMSMN1; SMN2HTTMAPT
SCHEMBL6463902 0.86 ALDH1A1 (0.54) ALDH1A1ATMSMN1; SMN2HTTMAPT
SCHEMBL6467200 0.83 ALDH1A1 (0.54) ALDH1A1ATMSMN1; SMN2HTTMAPT
SCHEMBL5567241 0.81 CACNA1H (0.50) CACNA1C
SCHEMBL6464188 0.80 ALDH1A1 (0.52) ALDH1A1ATMSMN1; SMN2HTTMAPT
SCHEMBL6465067 0.80 ALDH1A1 (0.47) ALDH1A1ATMSMN1; SMN2HTTMAPT
SCHEMBL5568429 0.75 CACNA1H (0.46) MAPTCACNA1C
SCHEMBL6528072 0.74 ALDH1A1 (0.54) ALDH1A1ATMSMN1; SMN2HTTMAPT
SCHEMBL5568065 0.73 CACNA1H (0.51) CACNA1C
SCHEMBL6533656 0.73 ALDH1A1 (0.47) ALDH1A1ATMSMN1; SMN2HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005009392-A2 DIHYDROPYRIMIDONE INHIBITORS OF CALCIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2005-02-03 WO disclosed